<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2011//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/DTD/pubmed_110101.dtd">
<pubmedarticleset>
 <pubmedarticle>
  <medlinecitation owner="NLM" status="MEDLINE">
   <pmid version="1">
    5335061
   </pmid>
   <datecreated>
    <year>
     1967
    </year>
    <month>
     04
    </month>
    <day>
     13
    </day>
   </datecreated>
   <datecompleted>
    <year>
     1967
    </year>
    <month>
     04
    </month>
    <day>
     13
    </day>
   </datecompleted>
   <daterevised>
    <year>
     2010
    </year>
    <month>
     11
    </month>
    <day>
     18
    </day>
   </daterevised>
   <article pubmodel="Print">
    <journal>
     <issn issntype="Print">
      0003-4967
     </issn>
     <journalissue citedmedium="Print">
      <volume>
       25
      </volume>
      <issue>
       6 Suppl
      </issue>
      <pubdate>
       <year>
        1966
       </year>
       <month>
        Nov
       </month>
      </pubdate>
     </journalissue>
     <title>
      Annals of the rheumatic diseases
     </title>
     <isoabbreviation>
      Ann. Rheum. Dis.
     </isoabbreviation>
    </journal>
    <articletitle>
     Treatment of gout with allopurinol and sulphinpyrazone in combination and with allopurinol alone.
    </articletitle>
    <pagination>
     <medlinepgn>
      634-42
     </medlinepgn>
    </pagination>
    <authorlist completeyn="Y">
     <author validyn="Y">
      <lastname>
       Kuzell
      </lastname>
      <forename>
       W C
      </forename>
      <initials>
       WC
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Seebach
      </lastname>
      <forename>
       L M
      </forename>
      <initials>
       LM
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Glover
      </lastname>
      <forename>
       R P
      </forename>
      <initials>
       RP
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Jackman
      </lastname>
      <forename>
       A E
      </forename>
      <initials>
       AE
      </initials>
     </author>
    </authorlist>
    <language>
     eng
    </language>
    <publicationtypelist>
     <publicationtype>
      Clinical Trial
     </publicationtype>
     <publicationtype>
      Comparative Study
     </publicationtype>
     <publicationtype>
      Journal Article
     </publicationtype>
    </publicationtypelist>
   </article>
   <medlinejournalinfo>
    <country>
     ENGLAND
    </country>
    <medlineta>
     Ann Rheum Dis
    </medlineta>
    <nlmuniqueid>
     0372355
    </nlmuniqueid>
    <issnlinking>
     0003-4967
    </issnlinking>
   </medlinejournalinfo>
   <chemicallist>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Enzymes
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      315-30-0
     </registrynumber>
     <nameofsubstance>
      Allopurinol
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      57-96-5
     </registrynumber>
     <nameofsubstance>
      Sulfinpyrazone
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      69-93-2
     </registrynumber>
     <nameofsubstance>
      Uric Acid
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      EC 1.17.3.2
     </registrynumber>
     <nameofsubstance>
      Xanthine Oxidase
     </nameofsubstance>
    </chemical>
   </chemicallist>
   <citationsubset>
    IM
   </citationsubset>
   <meshheadinglist>
    <meshheading>
     <descriptorname majortopicyn="N">
      Acute Kidney Injury
     </descriptorname>
     <qualifiername majortopicyn="N">
      drug therapy
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Adult
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Aged
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Allopurinol
     </descriptorname>
     <qualifiername majortopicyn="N">
      adverse effects
     </qualifiername>
     <qualifiername majortopicyn="N">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Arthritis, Rheumatoid
     </descriptorname>
     <qualifiername majortopicyn="N">
      drug therapy
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Clinical Trials as Topic
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Duodenal Ulcer
     </descriptorname>
     <qualifiername majortopicyn="N">
      drug therapy
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Enzymes
     </descriptorname>
     <qualifiername majortopicyn="Y">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Female
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Gout
     </descriptorname>
     <qualifiername majortopicyn="Y">
      drug therapy
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Humans
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Male
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Middle Aged
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Psoriasis
     </descriptorname>
     <qualifiername majortopicyn="N">
      drug therapy
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Sulfinpyrazone
     </descriptorname>
     <qualifiername majortopicyn="N">
      adverse effects
     </qualifiername>
     <qualifiername majortopicyn="Y">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Uric Acid
     </descriptorname>
     <qualifiername majortopicyn="N">
      blood
     </qualifiername>
     <qualifiername majortopicyn="N">
      urine
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="Y">
      Xanthine Oxidase
     </descriptorname>
    </meshheading>
   </meshheadinglist>
   <otherid source="NLM">
    PMC2453410
   </otherid>
  </medlinecitation>
  <pubmeddata>
   <history>
    <pubmedpubdate pubstatus="pubmed">
     <year>
      1966
     </year>
     <month>
      11
     </month>
     <day>
      1
     </day>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="medline">
     <year>
      1966
     </year>
     <month>
      11
     </month>
     <day>
      1
     </day>
     <hour>
      0
     </hour>
     <minute>
      1
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="entrez">
     <year>
      1966
     </year>
     <month>
      11
     </month>
     <day>
      1
     </day>
     <hour>
      0
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
   </history>
   <publicationstatus>
    ppublish
   </publicationstatus>
   <articleidlist>
    <articleid idtype="pubmed">
     5335061
    </articleid>
    <articleid idtype="pmc">
     PMC2453410
    </articleid>
   </articleidlist>
  </pubmeddata>
 </pubmedarticle>
</pubmedarticleset>

